The focus of this presentation is to discuss the emergence of MIS-C, the clinical characteristics of MIS-C, the pathophysiology of MIS-C, and the long term outcomes. The presentation was recorded at Advances in Pediatric Healthcare 2021, on Oct. 28, 2021.
Program Director, Rheumatology Program
Assistant Professor of Pediatrics, Harvard Medical School
At the conclusion of this educational program, learners will be able to:
- Discuss the emergence of MIS-C.
- Discuss the clinical characteristics of MIS-C.
- Discuss the pathophysiology of MIS-C.
- Discuss long term outcomes.
Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
This activity meets the requirements for 0.75 Risk Management Credits as proscribed by the Massachusetts Board of Registration in Medicine and defined in 243 CMR 2.06(5)(d) I. Please check your individual state licensing board requirements before claiming these credits.
Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Mary Beth Son, MD: None